The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI

Ce que rapporte la source

Personalized cancer vaccines are creating a diagnostics investment opportunity beyond Moderna and Merck, with tumor sequencing at its center.The postThe Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AIappeared first onBeInCrypto.